Meeting
2019 ASCO Annual Meeting
Genomic testing and treatment landscape in patients with advanced non-small cell lung cancer (aNSCLC) using real-world data from community oncology practices.
Authors
Hinco Jasper Gierman
Integra Connect, West Palm Beach, FL
Hinco Jasper Gierman , Seth Goldfarb , Monica Labrador , Caroline M. Weipert , Bill Getty , Stan M Skrzypczak , Casey Catasus , Steve Carbral , Mallika Singaraju , Nick Singleton , Nikhil Pai , Jose Sanchez , Jennifer Webster , Victoria M. Raymond , Richard B. Lanman , Ash Malik , Jeffrey A. Scott
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 37, 2019 (suppl; abstr 1585)
DOI
10.1200/JCO.2019.37.15_suppl.1585
Abstract #
1585
Poster Bd #
79
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting.
First Author: Mo Yang
Poster
2020 ASCO Virtual Scientific Program
Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study.
First Author: Adam Gondos
Poster
2023 ASCO Annual Meeting
Utility of ctDNA tumor fraction to inform negative liquid biopsy (LBx) results and need for tissue reflex in advanced non-small cell lung cancer (aNSCLC).
First Author: Christian Diego Rolfo
Poster
2021 ASCO Quality Care Symposium
Biomarker testing patterns in patients with stage IV non-small cell lung cancer (NSCLC) in U.S. community-based oncology practice setting.
First Author: Anthony Sireci